Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
Authors
Keywords
-
Journal
Cancer Medicine
Volume 8, Issue 5, Pages 2414-2428
Publisher
Wiley
Online
2019-04-08
DOI
10.1002/cam4.2114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC
- (2018) Tsatsral Iderzorig et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing
- (2018) Sarah V. Gerhart et al. Scientific Reports
- PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma
- (2018) Hai Jiang et al. Cancer Medicine
- Abstract 4859: JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potentin vitroandin vivoactivity, demonstrated in several lung cancer models
- (2018) Tongfei Wu et al. CANCER RESEARCH
- LKB1 regulates PRMT5 activity in breast cancer
- (2018) Hanine Lattouf et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Arginine Methylation: The Coming of Age
- (2017) Roméo S. Blanc et al. MOLECULAR CELL
- PRMT5 as a druggable target for glioblastoma therapy
- (2017) Yeshavanth Kumar Banasavadi-Siddegowda et al. NEURO-ONCOLOGY
- Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype
- (2017) Fangyuan Shao et al. Oncotarget
- PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression
- (2017) Kelly Chiang et al. Cell Reports
- High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors
- (2017) Céline Chauvin et al. Cell Reports
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
- (2016) Yanli Jin et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
- (2016) Konstantinos J. Mavrakis et al. SCIENCE
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
- (2015) Nicole Stopa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response
- (2015) Hsin-Wei Liao et al. JOURNAL OF CLINICAL INVESTIGATION
- TIPIN depletion leads to apoptosis in breast cancer cells
- (2015) Céline Baldeyron et al. Molecular Oncology
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
- (2015) Elayne Chan-Penebre et al. Nature Chemical Biology
- Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression
- (2015) Fan Yang et al. TUMOR BIOLOGY
- Triple-negative breast cancer: new perspectives for targeted therapies
- (2015) Silverio Tomao et al. OncoTargets and Therapy
- Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
- (2015) Kenneth W. Duncan et al. ACS Medicinal Chemistry Letters
- Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis
- (2015) Dong Hu et al. Nature Communications
- Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
- (2015) Sylvie Maubant et al. PLoS One
- Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
- (2014) Fengting Yan et al. CANCER RESEARCH
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- Protein arginine methyltransferase 5 is essential for growth of lung cancer cells
- (2012) Zhongping Gu et al. BIOCHEMICAL JOURNAL
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- Arginine methylation controls growth regulation by E2F-1
- (2012) Er-Chieh Cho et al. EMBO JOURNAL
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Protein Arginine Methyltransferase 5 Functions in Opposite Ways in the Cytoplasm and Nucleus of Prostate Cancer Cells
- (2012) Zhongping Gu et al. PLoS One
- Protein Arginine Methyltransferase 5 Accelerates Tumor Growth by Arginine Methylation of the Tumor Suppressor Programmed Cell Death 4
- (2011) M. A. Powers et al. CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
- (2011) Jung-Mao Hsu et al. NATURE CELL BIOLOGY
- Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
- (2010) L de Plater et al. BRITISH JOURNAL OF CANCER
- Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency
- (2010) W.-W. Tee et al. GENES & DEVELOPMENT
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- PRMT5 is required for cell-cycle progression and p53 tumor suppressor function
- (2009) A. Scoumanne et al. NUCLEIC ACIDS RESEARCH
- Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells
- (2008) L. Wang et al. MOLECULAR AND CELLULAR BIOLOGY
- Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer
- (2008) Yi Peng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now